Logo image of RBT

RUBICON TECHNOLOGIES INC (RBT) Stock Fundamental Analysis

NYSE:RBT - New York Stock Exchange, Inc. - US78112J2087 - Common Stock - Currency: USD

0.1715  -0.01 (-6.28%)

After market: 0.1156 -0.06 (-32.59%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RBT. RBT was compared to 281 industry peers in the Software industry. Both the profitability and financial health of RBT have multiple concerns. RBT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RBT has reported negative net income.
In the past year RBT has reported a negative cash flow from operations.
RBT had negative earnings in each of the past 5 years.
In the past 5 years RBT always reported negative operating cash flow.
RBT Yearly Net Income VS EBIT VS OCF VS FCFRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -50M -100M -150M -200M -250M

1.2 Ratios

RBT's Return On Assets of -35.08% is on the low side compared to the rest of the industry. RBT is outperformed by 79.71% of its industry peers.
Industry RankSector Rank
ROA -35.08%
ROE N/A
ROIC N/A
ROA(3y)-27.33%
ROA(5y)-30.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RBT Yearly ROA, ROE, ROICRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

RBT's Gross Margin of 7.17% is on the low side compared to the rest of the industry. RBT is outperformed by 89.13% of its industry peers.
In the last couple of years the Gross Margin of RBT has grown nicely.
RBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.91%
GM growth 5YN/A
RBT Yearly Profit, Operating, Gross MarginsRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -10 -20 -30

More info and screens

0

2. Health

2.1 Basic Checks

RBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBT has more shares outstanding than it did 1 year ago.
RBT has a worse debt/assets ratio than last year.
RBT Yearly Shares OutstandingRBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M
RBT Yearly Total Debt VS Total AssetsRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.58, we must say that RBT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.58, RBT is doing worse than 76.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.58
ROIC/WACCN/A
WACC8.1%
RBT Yearly LT Debt VS Equity VS FCFRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M

2.3 Liquidity

RBT has a Current Ratio of 0.69. This is a bad value and indicates that RBT is not financially healthy enough and could expect problems in meeting its short term obligations.
RBT has a Current ratio of 0.69. This is amonst the worse of the industry: RBT underperforms 89.13% of its industry peers.
A Quick Ratio of 0.69 indicates that RBT may have some problems paying its short term obligations.
RBT has a Quick ratio of 0.69. This is amonst the worse of the industry: RBT underperforms 88.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
RBT Yearly Current Assets VS Current LiabilitesRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

RBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -90.09%.
The Revenue has decreased by -2.45% in the past year.
Measured over the past years, RBT shows a quite strong growth in Revenue. The Revenue has been growing by 8.95% on average per year.
EPS 1Y (TTM)-90.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.5%
Revenue 1Y (TTM)-2.45%
Revenue growth 3Y8.95%
Revenue growth 5YN/A
Sales Q2Q%-9.96%

3.2 Future

Based on estimates for the next years, RBT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.65% on average per year.
Based on estimates for the next years, RBT will show a quite strong growth in Revenue. The Revenue will grow by 10.05% on average per year.
EPS Next Y63.16%
EPS Next 2Y30.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.48%
Revenue Next 2Y7.88%
Revenue Next 3Y10.42%
Revenue Next 5Y10.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
RBT Yearly Revenue VS EstimatesRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
RBT Yearly EPS VS EstimatesRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBT Price Earnings VS Forward Price EarningsRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBT Per share dataRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as RBT's earnings are expected to grow with 30.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.65%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RUBICON TECHNOLOGIES INC

NYSE:RBT (6/7/2024, 8:04:01 PM)

After market: 0.1156 -0.06 (-32.59%)

0.1715

-0.01 (-6.28%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-20 2024-05-20/amc
Earnings (Next)08-06 2024-08-06/amc
Inst Owners0.24%
Inst Owner Change0%
Ins Owners72.64%
Ins Owner Change0%
Market Cap9.58M
Analysts80
Price Target1.58 (821.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.42%
Min EPS beat(2)0.99%
Max EPS beat(2)19.85%
EPS beat(4)4
Avg EPS beat(4)26.56%
Min EPS beat(4)0.99%
Max EPS beat(4)53.04%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.95%
Min Revenue beat(2)-11.44%
Max Revenue beat(2)-0.46%
Revenue beat(4)1
Avg Revenue beat(4)-3.74%
Min Revenue beat(4)-11.44%
Max Revenue beat(4)0.6%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-24.39%
PT rev (3m)-24.39%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)12.73%
EPS NY rev (1m)-19.23%
EPS NY rev (3m)19.04%
Revenue NQ rev (1m)-8.52%
Revenue NQ rev (3m)-10.28%
Revenue NY rev (1m)-2.64%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS12.17
BVpS-2.56
TBVpS-3.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.17%
FCFM N/A
ROA(3y)-27.33%
ROA(5y)-30.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.91%
GM growth 5YN/A
F-Score3
Asset Turnover3.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.76%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z -0.58
F-Score3
WACC8.1%
ROIC/WACCN/A
Cap/Depr(3y)32.16%
Cap/Depr(5y)28.05%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.5%
EPS Next Y63.16%
EPS Next 2Y30.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.45%
Revenue growth 3Y8.95%
Revenue growth 5YN/A
Sales Q2Q%-9.96%
Revenue Next Year2.48%
Revenue Next 2Y7.88%
Revenue Next 3Y10.42%
Revenue Next 5Y10.05%
EBIT growth 1Y82.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.47%
EBIT Next 3Y37.32%
EBIT Next 5Y33.73%
FCF growth 1Y-27.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.5%
OCF growth 3YN/A
OCF growth 5YN/A